As we get over the hump of third-quarter financial reports, Scrip has taken a look at updates from the big PD-1/PD-L1 players, creating a handy calendar of key data readouts to watch for this winter and into 2017.
According to Informa Pharma Intelligence's Trialtrove database there are currently 904 ongoing clinical trials for immuno-oncology agents in the US and the top three most popular indications are